MEI Pharma Pioneers Litecoin Treasury Strategy With $100 Million Commitment, Stock Surges
MEI Pharma (MEIP), a NASDAQ-listed pharmaceutical company, has finalized a $100 million private placement to initiate a pioneering Litecoin (LTC) treasury strategy. Since announcing its pivot toward adopting LTC as a reserve asset, the firm’s stock price has surged. Over the past five days, MEIP has pumped over 100%, signaling investor confidence in the firm’s…
